APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Papillomavirus (HPV) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Papillomavirus (HPV) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173999960326 December 2025172 pages

Choose your research edition.

Industry ResearchHuman Papillomavirus (HPV) Vaccines Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Papillomavirus (HPV) Vaccines Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Human Papillomavirus (HPV) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Papillomavirus (HPV) Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Papillomavirus (HPV) Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Papillomavirus (HPV) Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Papillomavirus (HPV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Papillomavirus (HPV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Papillomavirus (HPV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Papillomavirus (HPV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Papillomavirus (HPV) Vaccines include Walvax, GSK and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Papillomavirus (HPV) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Papillomavirus (HPV) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Papillomavirus (HPV) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Papillomavirus (HPV) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Papillomavirus (HPV) Vaccines Segment by Company

Walvax

GSK

Merck

Human Papillomavirus (HPV) Vaccines Segment by Type

2-Valent Vaccine

4-Valent Vaccine

Human Papillomavirus (HPV) Vaccines Segment by Application

Research & Academic Laboratories

Pharmaceutical & Biotechnology Companies

Others

Human Papillomavirus (HPV) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Papillomavirus (HPV) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Papillomavirus (HPV) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Papillomavirus (HPV) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Papillomavirus (HPV) Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Papillomavirus (HPV) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Papillomavirus (HPV) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Papillomavirus (HPV) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Papillomavirus (HPV) Vaccines Industry Trends Table 2. Human Papillomavirus (HPV) Vaccines Industry Drivers Table 3. Human Papillomavirus (HPV) Vaccines Industry Opportunities and Challenges Table 4. Human Papillomavirus (HPV) Vaccines Industry Restraints Table 5. Global Human Papillomavirus (HPV) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Papillomavirus (HPV) Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Manufacturers Table 9. Global Human Papillomavirus (HPV) Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human Papillomavirus (HPV) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Papillomavirus (HPV) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Papillomavirus (HPV) Vaccines Manufacturers, Product Type & Application Table 13. Global Human Papillomavirus (HPV) Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Papillomavirus (HPV) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2-Valent Vaccine Table 17. Major Manufacturers of 4-Valent Vaccine Table 18. Global Human Papillomavirus (HPV) Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2027-2032) & (K Units) Table 21. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Human Papillomavirus (HPV) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2021-2026) & (K Units) Table 25. Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2027-2032) & (K Units) Table 26. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Research & Academic Laboratories Table 29. Major Manufacturers of Pharmaceutical & Biotechnology Companies Table 30. Major Manufacturers of Others Table 31. Global Human Papillomavirus (HPV) Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2021-2026) & (K Units) Table 33. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2027-2032) & (K Units) Table 34. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Human Papillomavirus (HPV) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Human Papillomavirus (HPV) Vaccines Revenue by Application (2021-2026) & (K Units) Table 38. Global Human Papillomavirus (HPV) Vaccines Revenue by Application (2027-2032) & (K Units) Table 39. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Human Papillomavirus (HPV) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Human Papillomavirus (HPV) Vaccines Sales by Region (2021-2026) & (K Units) Table 43. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Human Papillomavirus (HPV) Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Human Papillomavirus (HPV) Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2026) & (K Units) Table 48. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2027-2032) & (K Units) Table 49. Europe Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2026) & (K Units) Table 51. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2027-2032) & (K Units) Table 58. Global Human Papillomavirus (HPV) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Human Papillomavirus (HPV) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Human Papillomavirus (HPV) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region (2027-2032) Table 63. Walvax Company Information Table 64. Walvax Business Overview Table 65. Walvax Human Papillomavirus (HPV) Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Walvax Human Papillomavirus (HPV) Vaccines Product Portfolio Table 67. Walvax Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Human Papillomavirus (HPV) Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GSK Human Papillomavirus (HPV) Vaccines Product Portfolio Table 72. GSK Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Human Papillomavirus (HPV) Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Human Papillomavirus (HPV) Vaccines Product Portfolio Table 77. Merck Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Human Papillomavirus (HPV) Vaccines Distributors List Table 81. Human Papillomavirus (HPV) Vaccines Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Human Papillomavirus (HPV) Vaccines Product Image Figure 2. Global Human Papillomavirus (HPV) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Papillomavirus (HPV) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Papillomavirus (HPV) Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Human Papillomavirus (HPV) Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Papillomavirus (HPV) Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2-Valent Vaccine Image Figure 9. 4-Valent Vaccine Image Figure 10. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Human Papillomavirus (HPV) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Research & Academic Laboratories Image Figure 17. Pharmaceutical & Biotechnology Companies Image Figure 18. Others Image Figure 19. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Human Papillomavirus (HPV) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Human Papillomavirus (HPV) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Human Papillomavirus (HPV) Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Human Papillomavirus (HPV) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Human Papillomavirus (HPV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human Papillomavirus (HPV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human Papillomavirus (HPV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Papillomavirus (HPV) Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Human Papillomavirus (HPV) Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 2-Valent Vaccine
  • 4-Valent Vaccine
Applications
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
Companies covered
  • Walvax
  • GSK
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Papillomavirus (HPV) Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Papillomavirus (HPV) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Papillomavirus (HPV) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Papillomavirus (HPV) Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Papillomavirus (HPV) Vaccines Market Dynamics
  1. 2.1 Human Papillomavirus (HPV) Vaccines Industry Trends
  2. 2.2 Human Papillomavirus (HPV) Vaccines Industry Drivers
  3. 2.3 Human Papillomavirus (HPV) Vaccines Industry Opportunities and Challenges
  4. 2.4 Human Papillomavirus (HPV) Vaccines Industry Restraints
3 Human Papillomavirus (HPV) Vaccines Market by Manufacturers
  1. 3.1 Global Human Papillomavirus (HPV) Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Papillomavirus (HPV) Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Papillomavirus (HPV) Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Papillomavirus (HPV) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Papillomavirus (HPV) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Papillomavirus (HPV) Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Human Papillomavirus (HPV) Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Papillomavirus (HPV) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Papillomavirus (HPV) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Papillomavirus (HPV) Vaccines Tier 1, Tier 2, and Tier 3
4 Human Papillomavirus (HPV) Vaccines Market by Type
  1. 4.1 Human Papillomavirus (HPV) Vaccines Type Introduction
  2. 4.1.1 2-Valent Vaccine
  3. 4.1.2 4-Valent Vaccine
  4. 4.2 Global Human Papillomavirus (HPV) Vaccines Sales by Type
  5. 4.2.1 Global Human Papillomavirus (HPV) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Papillomavirus (HPV) Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Human Papillomavirus (HPV) Vaccines Revenue by Type
  9. 4.3.1 Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Papillomavirus (HPV) Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Type (2021-2032)
5 Human Papillomavirus (HPV) Vaccines Market by Application
  1. 5.1 Human Papillomavirus (HPV) Vaccines Application Introduction
  2. 5.1.1 Research & Academic Laboratories
  3. 5.1.2 Pharmaceutical & Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Human Papillomavirus (HPV) Vaccines Sales by Application
  6. 5.2.1 Global Human Papillomavirus (HPV) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Papillomavirus (HPV) Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Papillomavirus (HPV) Vaccines Revenue by Application
  10. 5.3.1 Global Human Papillomavirus (HPV) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Papillomavirus (HPV) Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Application (2021-2032)
6 Global Human Papillomavirus (HPV) Vaccines Sales by Region
  1. 6.1 Global Human Papillomavirus (HPV) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Papillomavirus (HPV) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Human Papillomavirus (HPV) Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Human Papillomavirus (HPV) Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Papillomavirus (HPV) Vaccines Revenue by Region
  1. 7.1 Global Human Papillomavirus (HPV) Vaccines Revenue by Region
  2. 7.1.1 Global Human Papillomavirus (HPV) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Papillomavirus (HPV) Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Papillomavirus (HPV) Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Papillomavirus (HPV) Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Papillomavirus (HPV) Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Papillomavirus (HPV) Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Papillomavirus (HPV) Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Papillomavirus (HPV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Walvax
  2. 8.1.1 Walvax Company Information
  3. 8.1.2 Walvax Business Overview
  4. 8.1.3 Walvax Human Papillomavirus (HPV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Walvax Human Papillomavirus (HPV) Vaccines Product Portfolio
  6. 8.1.5 Walvax Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Human Papillomavirus (HPV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Human Papillomavirus (HPV) Vaccines Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Human Papillomavirus (HPV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Human Papillomavirus (HPV) Vaccines Product Portfolio
  18. 8.3.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Papillomavirus (HPV) Vaccines Value Chain Analysis
  2. 9.1.1 Human Papillomavirus (HPV) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Papillomavirus (HPV) Vaccines Production Mode & Process
  6. 9.2 Human Papillomavirus (HPV) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Papillomavirus (HPV) Vaccines Distributors
  9. 9.2.3 Human Papillomavirus (HPV) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst